David R. Snydman
#117,020
Most Influential Person Now
Researcher
David R. Snydman's AcademicInfluence.com Rankings
David R. Snydmanengineering Degrees
Engineering
#3586
World Rank
#4688
Historical Rank
Electrical Engineering
#819
World Rank
#887
Historical Rank
David R. Snydmancomputer-science Degrees
Computer Science
#4598
World Rank
#4851
Historical Rank
Data Science
#62
World Rank
#63
Historical Rank
Computational Linguistics
#472
World Rank
#480
Historical Rank
Machine Learning
#953
World Rank
#967
Historical Rank
Download Badge
Engineering Computer Science
David R. Snydman's Degrees
- Masters Electrical Engineering Stanford University
Why Is David R. Snydman Influential?
(Suggest an Edit or Addition)David R. Snydman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. (1977) (1181)
- Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. (2001) (1062)
- Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial (1994) (889)
- The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. (1996) (797)
- Epidemiology of sepsis syndrome in 8 academic medical centers. (1997) (692)
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic‐Cell Transplantation (2017) (643)
- Risk and safety of probiotics. (2015) (546)
- Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. (1987) (512)
- An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. (2003) (460)
- International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. (2010) (443)
- Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group (1994) (438)
- Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. (2004) (432)
- Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. (1995) (387)
- The safety of probiotics. (2008) (362)
- Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study (2001) (318)
- The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. (1997) (299)
- Cytomegalovirus in Solid Organ Transplant Recipients (2009) (286)
- Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. (2008) (281)
- Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs (2016) (275)
- Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. (2005) (262)
- Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. (1983) (262)
- Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients (1995) (247)
- Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. (1998) (227)
- Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. (2003) (226)
- Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. (2000) (207)
- Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation (1993) (201)
- Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. (1984) (199)
- Predicting Bacteremia in Patients with Sepsis Syndrome (1997) (195)
- Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. (2000) (195)
- PREDICTIVE VALUE OF SURVEILLANCE SKIN CULTURES IN TOTAL-PARENTERAL-NUTRITION-RELATED INFECTION (1982) (193)
- Cytomegalovirus prophylaxis in solid organ transplant recipients. (1996) (188)
- Lactobacillus GG: bacteriology and clinical applications. (2005) (185)
- Total parenteral nutrition-related infections. Prospective epidemiologic study using semiquantitative methods. (1982) (181)
- Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality (2006) (176)
- Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial (2007) (168)
- Outcome of transplantation of organs procured from bacteremic donors. (1999) (167)
- Clinical Utility of Blood Cultures Drawn from Indwelling Central Venous Catheters in Hospitalized Patients with Cancer (1999) (167)
- Lactobacillus GG as an Immune Adjuvant for Live Attenuated Influenza Vaccine in Healthy Adults: A Randomized Double Blind Placebo Controlled Trial (2011) (161)
- Fluconazole MIC and the Fluconazole Dose/MIC Ratio Correlate with Therapeutic Response among Patients with Candidemia (2005) (157)
- Borrelia burgdorferi in joint fluid in chronic Lyme arthritis. (1986) (156)
- Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies. (2006) (156)
- National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004 (2007) (150)
- Shifting patterns in the epidemiology of nosocomial Candida infections. (2003) (148)
- Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis. (2002) (147)
- Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). (2010) (142)
- Infection in solid organ transplantation (1999) (140)
- Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. (1998) (139)
- Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006 (2009) (132)
- The clinical spectrum and treatment of Lyme disease. (1984) (129)
- Influence of blood culture results on antibiotic choice in the treatment of bacteremia. (1994) (122)
- Staphylococcus aureus Native Valve Infective Endocarditis: Report of 566 Episodes From the International Collaboration on Endocarditis Merged DatabaseMiro JM, and the International Collaboration on Endocarditis Merged Database Study Group (Univ of Barcelona; et al) Clin Infect Dis 41:507–514, 2005§ (2006) (120)
- Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts. (1985) (117)
- Attributable mortality of bacteremia associated with the Bacteroides fragilis group. (1995) (106)
- Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation. (2003) (106)
- Attributable mortality of Stenotrophomonas maltophilia bacteremia. (2002) (104)
- Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. (2011) (104)
- Epidemiology of infections after solid-organ transplantation. (2001) (104)
- Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy. (2014) (101)
- Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive Pathogens (2000) (100)
- Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009. (2011) (100)
- Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis. (1979) (99)
- Infective endocarditis in solid organ transplant recipients. (1998) (98)
- Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy. (2004) (97)
- Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group. (1996) (96)
- Multicenter Study of In Vitro Susceptibility of theBacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996 (1999) (96)
- Nosocomial sepsis associated with interleukin-2. (1990) (95)
- Organ donor screening for infectious diseases: review of practice and implications for transplantation. (1998) (94)
- NATIONAL SURVEY ON THE SUSCEPTIBILITY OF BACTEROIDES FRAGILIS GROUP: REPORT AND ANALYSIS OF TRENDS FOR 1997–2000 (2002) (93)
- Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis BLai C-L, for the BEHoLD AI463027 Study Group (Queen Mary Hosp, Hong Kong; et al) N Engl J Med 354:1011–1020, 2006§ (2007) (89)
- Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections (1996) (88)
- Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis* (2003) (88)
- Effect of Cytomegalovirus Infection Status on First-Year Mortality Rates among Orthotopic Liver Transplant Recipients (1997) (88)
- A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. (1984) (87)
- Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance. (1998) (85)
- Avian Influenza A (H5N1) Infection in Eastern Turkey in 2006 (2007) (82)
- Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. (1997) (80)
- Intravenous Tubing Containing Burettes Can Be Safely Changed at 72 Hour Intervals (1987) (80)
- Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin (1993) (79)
- Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. (2007) (79)
- Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group. (1998) (76)
- Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease. (1990) (75)
- Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group. (1997) (75)
- Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. (2001) (75)
- Cytomegalovirus infection in organ transplant recipients. (1995) (72)
- Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated (2011) (71)
- Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients. (1997) (71)
- Management and Outcomes of a First Recurrence of Clostridium difficile–Associated Disease in Quebec, Canada (2007) (71)
- Clinical utility of blood cultures drawn from central venous or arterial catheters in critically ill surgical patients (2002) (71)
- Late and atypical cytomegalovirus disease in solid-organ transplant recipients. (2001) (70)
- Hypogammaglobulinemia in Liver Transplant Recipients: Incidence, Timing, Risk Factors, and Outcomes (2006) (69)
- Emergence of fluoroquinolone resistance among Bacteroides species. (2003) (69)
- Characterization of pBFTM10, a clindamycin-erythromycin resistance transfer factor from Bacteroides fragilis (1982) (67)
- Nosocomial viral hepatitis B. A cluster among staff with subsequent transmission to patients. (1976) (67)
- The impact of gown-use requirement on hand hygiene compliance. (2006) (66)
- Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients (2016) (66)
- A nationwide survey of antimicrobial stewardship practices. (2013) (66)
- Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy. (2004) (65)
- In Vitro Activities of Tigecycline against the Bacteroides fragilis Group (2004) (65)
- The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients. (2004) (65)
- A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis BChang T-T, for the BEHoLD AI463022 Study Group (Natl Cheng Kung Univ, Tainan, Taiwan; et al) N Engl J Med 354:1001–1010, 2006§ (2007) (64)
- The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products (1990) (63)
- Severe sepsis: variation in resource and therapeutic modality use among academic centers (2003) (63)
- Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis. (1998) (62)
- The case for cytomegalovirus prophylaxis in solid organ transplantation (2006) (60)
- Spectrum and significance of bacteremia due to Moraxella catarrhalis. (1995) (60)
- Hemodialysis-associated hepatitis: report of an epidemic with further evidence on mechanisms of transmission. (1976) (59)
- Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence. (2013) (59)
- Clinical implications of multi-drug resistance in the intensive care unit. (1991) (58)
- Hemodialysis-Associated Hepatitis in the United States, 1974 (1977) (56)
- Late incidence of cancer after metronidazole use: a matched metronidazole user/nonuser study. (1998) (55)
- Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia. (1988) (54)
- Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens (2012) (54)
- Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis (1992) (53)
- Viral Prophylaxis in Organ Transplant Patients (2005) (53)
- Hepatitis in pregnancy. (1985) (53)
- Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis (2007) (52)
- U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin (2015) (52)
- Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007. (2008) (51)
- Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. (1996) (50)
- The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987. (1990) (50)
- Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study (2018) (50)
- Intravenous tubing with burettes can be safely changed at 48-hour intervals. (1984) (49)
- Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse (1980) (49)
- Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates (1995) (49)
- Evaluation of In Vitro Interaction of Daptomycin with Gentamicin or Beta-lactam Antibiotics Against taphylococcus aureus and Enterococci by FIC Index and Timed-Kill Curves (2005) (49)
- Prevention of nosocomial transmission of respiratory syncytial virus in a newborn nursery. (1988) (48)
- Endocarditis and pericarditis complicating pneumococcal bacteraemia, with special reference to the adhesive abilities of pneumococci: results from a prospective study. (2006) (48)
- Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009. (2017) (47)
- Prevention and treatment of central venous catheter sepsis by exchange via a guidewire. (1984) (46)
- Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006 (2010) (46)
- Nosocomial infections in skilled nursing facilities: a preliminary survey. (1979) (45)
- In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms (2002) (45)
- Clinical and Epidemiological Predictors of Recurrent Cytomegalovirus Disease in Orthotopic Liver Transplant Recipients (1997) (45)
- Recurrent cytomegalovirus disease in solid-organ transplant recipients. (1995) (44)
- Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation (2001) (43)
- Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis. (2005) (42)
- Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis. (1991) (42)
- No Evidence of Harms of Probiotic Lactobacillus rhamnosus GG ATCC 53103 in Healthy Elderly—A Phase I Open Label Study to Assess Safety, Tolerability and Cytokine Responses (2014) (42)
- A multifaceted approach to education, observation, and feedback in a successful hand hygiene campaign. (2011) (42)
- Ganciclovir therapy for cytomegalovirus disease associated with renal transplants. (1988) (42)
- Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients (2018) (41)
- Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group (1997) (41)
- Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation (2014) (41)
- A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccination. (1984) (40)
- Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation (2005) (40)
- Vancomycin-resistant enterococcal infections in bone marrow transplant recipients (1998) (39)
- A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT) (2015) (39)
- Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections. (2011) (38)
- Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates (2018) (38)
- Antibiotic Exposure and Room Contamination Among Patients Colonized With Vancomycin-Resistant Enterococci (2008) (37)
- Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease. (1989) (37)
- Infectious mononucleosis in an adult progressing to fatal immunoblastic lymphoma. (1982) (37)
- Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccination. (1985) (36)
- Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients (2019) (36)
- A pilot trial of a novel cytomegalovirus immune globulin in renal transplant recipients. (1984) (35)
- Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients (2017) (35)
- New developments in cytomegalovirus prevention and management. (1993) (35)
- Activity of Ceftolozane-Tazobactam against a Broad Spectrum of Recent Clinical Anaerobic Isolates (2013) (35)
- Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study. (2001) (34)
- High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. (2011) (34)
- Increased serum iron levels and infectious complications after liver transplantation. (2010) (34)
- Transmission of hepatitis B associated with hemodialysis: role of malfunction (blood leaks) in dialysis machines. (1976) (34)
- Incidence and predictors of cytomegalovirus pneumonia in orthotopic liver transplant recipients (1996) (34)
- Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials. (1991) (34)
- Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin (2018) (33)
- Daptomycin for line-related Leuconostoc bacteraemia. (2001) (33)
- Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis (2009) (33)
- Transmission of vancomycin-resistant enterococcus in a neonatal intensive care unit. (2005) (32)
- Vancomycin‐Resistant Enterococcus Infections in Solid Organ Transplantation (2013) (32)
- Use of immune globulins in the prevention and treatment of infections. (1992) (32)
- Diagnosis and management of diarrhea in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice (2019) (32)
- Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study Group. (1993) (31)
- Pseudobacteremia: false-positive blood cultures from mist tent contamination. (1977) (31)
- Prevention of nosocomial viral hepatitis, type B (hepatitis B). (1975) (31)
- Acquired immunodeficiency syndrome with progressive multifocal leukoencephalopathy and monoclonal B-cell proliferation. (1984) (30)
- The impact of CMV prevention on long‐term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database (2011) (30)
- Hemodialysis-associated hepatitis in the United States--1972. (1975) (30)
- Real-time antifungal susceptibility screening aids management of invasive yeast infections in immunocompromised patients. (2002) (29)
- Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities (2015) (29)
- Prevention of cytomegalovirus-associated diseases with immunoglobulin. (1991) (28)
- An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cells. (1990) (28)
- Posttransplant microbiological surveillance. (2001) (28)
- A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT (2011) (27)
- A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trial. (1988) (27)
- Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group. (1996) (27)
- In Vitro Activity of Ceftaroline against a Broad Spectrum of Recent Clinical Anaerobic Isolates (2010) (27)
- Resource Utilization Among Patients With Sepsis Syndrome (2003) (27)
- Clinical Manifestations and Molecular Epidemiology of Late Recurrent Candidemia, and Implications for Management (2000) (26)
- In Vitro Activities of Doripenem, a New Broad-Spectrum Carbapenem, against Recently Collected Clinical Anaerobic Isolates, with Emphasis on the Bacteroides fragilis Group (2008) (26)
- Mechanism of Resistance in Metronidazole (2009) (26)
- Antifungal Prophylaxis for Solid Organ Transplant Recipients : Seeking Clarity Amidst Controversy (26)
- Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges (2007) (25)
- Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group. (1997) (25)
- Netilmicin in Gram-Negative Bacterial Infections (1979) (25)
- Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities (1980) (24)
- Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Boston Center for Liver Transplantation Cytomegalovirus Immune Globulin Study Group. (1997) (24)
- Cytomegalovirus Prevention and Long-Term Recipient and Graft Survival in Pediatric Heart Transplant Recipients (2010) (23)
- Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients (2016) (22)
- Review of the efficacy of cytomegalovirus immune globulin in the prophylaxis of CMV disease in renal transplant recipients. (1993) (21)
- Infections Associated With Tumor Necrosis Factor-α Antagonists (2006) (20)
- Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids (2020) (20)
- U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016 (2019) (20)
- Persistent babesiosis in a stem cell transplant recipient. (2011) (19)
- A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group. (1994) (19)
- Transplant Infections (2016) (18)
- Characteristics and outcomes of neutropenia after orthotopic liver transplantation (2016) (18)
- Why did maribavir fail in stem-cell transplants? (2011) (18)
- Repeated enzyme immunoassays have limited utility in diagnosing Clostridium difficile (2008) (18)
- First report of a left ventricular assist device infection caused by Staphylococcus schleiferi subspecies coagulans: a coagulase-positive organism. (2012) (17)
- Ocular and pericardial involvement in Legionnaires' disease. (1984) (17)
- Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group. (1993) (17)
- Physician report cards and rankings yield long-lasting hand hygiene compliance exceeding 90 % (2015) (17)
- Cytomegalovirus immune globulin after liver transplantation: a cost‐effectiveness analysis 1 (2000) (17)
- Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination. (1985) (17)
- Human Immunodeficiency Virus Infection in Hemodialysis Patients (1988) (17)
- Epidemiology, risk factors, and outcomes associated with cytomegalovirus in adult kidney transplant recipients: A systematic literature review of real‐world evidence (2020) (16)
- Blood Stream Infection (BSI) and Acute Graft Versus Host Disease (GVHD) after Hematopoietic Stem Cell Transplantation (HSCT) are Associated (2007) (16)
- Use of IgM-hepatitis A antibody testing. Investigating a common-source, food borne outbreak. (1981) (16)
- Cytomegalovirus prophylaxis strategies in high-risk transplantation. (1994) (15)
- Comparative In Vitro Activities of Clinafloxacin and Trovafloxacin against 1,000 Isolates of Bacteroides fragilisGroup: Effect of the Medium on Test Results (2000) (15)
- Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates. (1987) (15)
- Outpatient parenteral antimicrobial therapy (OPAT) in the republic of Ireland: results of a national survey (2013) (15)
- Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin (2018) (14)
- Antiviral immunotherapy: a review of current status. (1998) (14)
- The impact of recurrent cytomegalovirus infection on long‐term survival in solid organ transplant recipients (2019) (14)
- In vitro evaluation of cytomegalovirus‐specific hyperimmune globulins vs. standard intravenous immunoglobulins (2015) (14)
- Characterization ofpBFTM10, aClindamycin-Erythromycin Resistance Transfer Factor fromBacteroides fragilis (1982) (14)
- Ertapenem Versus Piperacillin/Tazobactam for Diabetic Foot Infections (SIDESTEP): Prospective, Randomized, Controlled, Double-blinded, Multicentre TrialLipsky BA, Armstrong DG, Citron DM, et al (Univ of Washington, Seattle; Rosalind Franklin Univ of Medicine and Science, Chicago; RM Alden Research L (2006) (14)
- Hemophilus aphrophilus osteomyelitis. (1984) (14)
- Prevention of catheter and intravascular device-related infections: a quality-of-care mandate for institutions and physicians. (2006) (14)
- Incidence and predictors of cytomegalovirus pneumonia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group. (1996) (13)
- In Vitro Evaluation of the Activity of Imipenem-Relebactam against 451 Recent Clinical Isolates of Bacteroides Group and Related Species (2016) (13)
- Predicting Clostridium difficile Stool Cytotoxin Results in Hospitalized Patients with Diarrhea (2006) (13)
- Prospective Observational Study Comparing Sepsis-2 and Sepsis-3 Definitions in Predicting Mortality in Critically Ill Patients (2019) (13)
- Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group. (2005) (13)
- Horizontal Infection Control Strategy Decreases Methicillin-Resistant Staphylococcus aureus Infection and Eliminates Bacteremia in a Surgical ICU Without Active Surveillance* (2014) (13)
- Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities. (1981) (12)
- Leflunomide: a small step forward in meeting the urgent need for treatment of drug-resistant cytomegalovirus infection. (2010) (12)
- Iron storage indices and risk of bacterial infections in hemodialysis patients (2004) (12)
- The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients. (2013) (12)
- The efficacy of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bloodstream infection in patients with impaired renal function. (2014) (12)
- Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine (2007) (12)
- Reactivation of latent cytomegalovirus infection in patients with rheumatologic disease: a case–control study (2019) (11)
- Prevention of cytomegalovirus disease in transplant recipients (1996) (11)
- Thin-layer chromatography of citric acid cycle intermediates, pyruvate and lactate. (1968) (10)
- Evaluation in a Multicenter, Prospective, Observational Study (2017) (10)
- Mortality Attributable to Nosocomial Clostridium difficile–Associated Disease During an Epidemic Caused by a Hypervirulent Strain in QuebecPépin J, Valiquette L, Cossette B (Univ of Sherbrooke, Quebec, Canada; Centre hospitalier universitaire de Sherbrooke, Quebec, Canada) CMAJ 173:1037–1041, 2005§ (2006) (10)
- Empiric antibiotic selection strategies for healthcare-associated pneumonia, intra-abdominal infections, and catheter-associated bacteremia. (2012) (10)
- Cytomegalovirus infection in solid organ transplantation: Prospects for prevention (1990) (10)
- Microbial Identification Using DNA Target Amplification and Sequencing: Clinical Utility and Impact on Patient Management (2018) (10)
- Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989. (1992) (10)
- Viral infections in the intensive care unit. (1993) (9)
- Carbapenem-Resistant Enterobacteriaceae: A Statewide Survey of Detection in Massachusetts Hospitals (2012) (9)
- Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy (2006) (9)
- Bacterial Food Poisoning (1982) (9)
- Iron‐related markers are associated with infection after liver transplantation (2017) (9)
- ANALYSIS OF THE IN VITRO ACTIVITY OF TROVAFLOXACIN (CP‐99,219) AGAINST BACTEROIDES SPECIES (1996) (9)
- Utility of Serial Rectal Swab Cultures for Detection of Ceftazidime- and Imipenem-Resistant Gram-Negative Bacilli from Patients in the Intensive Care Unit (1998) (8)
- Demonstration of Borrelia burgdorferi in a patient with chronic Lyme arthritis. (1986) (8)
- Aspergillus fumigatus infection of a biloma. (1995) (8)
- Aspergillus brain abscess after liver transplantation with long-term survival. A case report. (1994) (8)
- Pneumocystis carinii and cytomegalovirus pneumonia in a previously healthy adult. (1982) (7)
- Persistent clinical impact of cytomegalovirus in organ transplantation. (2008) (7)
- Reemergence of Early Pandemic Staphylococcus aureus as a Community-acquired Meticillin-Resistant CloneRobinson DA, Kearns AM, Holmes A, et al (Univ of Bath, England; Health Protection Agency, London; Stobhill Hosp, Glasgow, Scotland; et al) Lancet 365:1256–1258, 2005§ (2006) (7)
- Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniaeWhitney CG, for Active Bacterial Core Surveillance of the Emerging Infections Program Network (Ctrs for Disease Control and Prevention, Atlanta, Ga; et al) N Engl J Med 354:1455–1463, 2006§ (2007) (7)
- Monotherapy is appropriate for nosocomial pneumonia in the intensive care unit. (1993) (7)
- The potential role for iron overload and fungal infection in liver transplantation (2006) (7)
- Historical perspective of Lyme disease. (1986) (7)
- Investigation of an Epidemic of Multi-Drug Resistant Pseudomonas aeruginosa (1982) (7)
- Selective method for identification and quantification of Bifidobacterium animalis subspecies lactis BB‐12 (BB‐12) from the gastrointestinal tract of healthy volunteers ingesting a combination probiotic of BB‐12 and Lactobacillus rhamnosus GG (2017) (6)
- Empiric antibiotic selection strategies for healthcare-associated pneumonia, intra-abdominal infections, and catheter-associated bacteremia. (2012) (6)
- A repeat offender: Recurrent extraintestinal Clostridium difficile infection following fecal microbiota transplantation. (2018) (6)
- Use of cytomegalovirus immune globulin. (1992) (6)
- Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIVGallant JE, for the Study 934 Group (Johns Hopkins Univ, Baltimore, Md; et al) N Engl J Med 354:251–260, 2006§ (2007) (5)
- Epidemiologic Trends in Clostridium difficile Isolate Ribotypes in United States from 2010 to 2014 (2017) (5)
- Progressive Multifocal Leukoencephalopathy in a Patient Treated With Natalizumab (2006) (5)
- Fatal Toxic Shock Syndrome Associated with Clostridium sordellii after Medical Abortion (2007) (5)
- Methicillin-Resistant S. aureus Infections among Patients in the Emergency DepartmentMoran GJ, for the EMERGEncy ID Net Study Group (Olive View-UCLA Med Ctr, Sylmar, Calif; et al) N Engl J Med 355:666–674, 2006§ (2007) (5)
- Amoxicillin-Clavulanate vs Ciprofloxacin for the Treatment of Uncomplicated Cystitis in Women: A Randomized TrialHooton TM, Scholes D, Gupta K, et al (Univ of Washington, Seattle; Group Health Cooperative, Seattle) JAMA 293:949–955, 2005§ (2006) (5)
- Mosby's color atlas and text of infectious diseases (2000) (5)
- Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin GenesFrancis JS, Doherty MC, Lopatin U, et al (Johns Hopkins Med Institutions, Baltimore, Md; NIH, Bethesda, Md) Clin Infect Dis 40:100–107, 2005§ (2006) (5)
- Antiviral Immunotherapy (1998) (5)
- Cytomegalovirus Prevention Strategies: The Case for Prophylaxis (2009) (4)
- Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016. (2020) (4)
- Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate VaccineLexau CA, for the Active Bacterial Core Surveillance Team (Minnesota Dept of Health, Minneapolis; et al) JAMA 294:2043–2051, 2005§ (2006) (4)
- Prevention of catheter-related bloodstream infections: looking to the department of veterans affairs health care system for guidance. (2007) (4)
- Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis. (1995) (4)
- Putting the IMPACT Study into Perspective: Should CMV Prophylaxis Be Extended to 6 Months for High Risk Transplants? (2011) (4)
- Carbapenem-resistant enterobacteriaceae: analyzing knowledge and practice in healthcare providers (2014) (4)
- Nosocomial Hepatitis C: More of a Hidden Epidemic (2012) (4)
- How effective is oral ganciclovir? (1996) (4)
- Evaluation of a two-stage testing algorithm for the diagnosis of respiratory viral infections (2018) (4)
- Antiviral Agents: Action and Clinical Use (1979) (4)
- Immunologic Responses to Hepatitis B Virus and their Interpretations (1984) (4)
- Editorial Commentary: Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Another Piece of the Puzzle. (2016) (4)
- Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin. (1995) (4)
- Hepatitis B infection from medical personnel. (1976) (4)
- Sputum: a diagnostic pitfall in alcoholics. (1978) (4)
- Reactivation of Latent Cytomegalovirus Infection after Major Surgery: Risk Factors and Outcomes. (2019) (4)
- A Predominantly Clonal Multi-Institutional Outbreak of Clostridium difficile–Associated Diarrhea With High Morbidity and MortalityLoo VG, Poirier L, Miller MA, et al (McGill Univ, Montreal; Université de Montréal; Hôpital Jean Talon, Montreal; et al) N Engl J Med 353:2442–2449, 2005§ (2006) (4)
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus (2007) (3)
- Impact of Routine Intensive Care Unit Surveillance Cultures and Resultant Barrier Precautions on Hospital-Wide Methicillin-Resistant Staphylococcus aureus BacteremiaHuang SS, Yokoe DS, Hinrichsen VL, et al (Channing Lab, Boston; Brigham and Women's Hosp, Boston, Harvard Med School) Clin Infect Dis 4 (2007) (3)
- Antiviral antibodies in transplantation. (1995) (3)
- Cytomegalovirus Infection in Critically Ill Patients (2006) (3)
- The effect of respiratory viral assay panel on antibiotic prescription patterns at discharge in adults admitted with mild to moderate acute exacerbation of COPD: a retrospective before- after study (2019) (3)
- NEORAL IS ASSOCIATED WITH LESS NEUROTOXICITY AFTER LIVER TRANSPLANTATION (1999) (3)
- Editorial commentary: the complexity of latent cytomegalovirus infection in stem cell donors. (2014) (3)
- Treatment of Severe Pneumonia in Hospitalised Patients (2012) (3)
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsOxman MN, for the Shingles Prevention Study Group (VA San Diego Healthcare System, Calif; et al) N Engl J Med 352:2271–2284, 2005§ (2006) (3)
- BACTERIA IN TOTAL PARENTERAL NUTRITION CATHETERS (1983) (3)
- Protective Effects of the 23-Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN-65 StudyVila-Córcoles A, and the EVAN Study Group (Catalonian Health Inst, Tarragona, Spain; et al) Clin Infect Dis 43:860–868, 2006§ (2007) (3)
- Destruction of isolates from the Pittsburgh Veterans Affairs Laboratory. (2008) (3)
- Prevention of cytomegalovirus disease with intravenous immune globulin (1991) (3)
- Lymphopenia: a novel predictor for recurrent cytomegalovirus disease in solid organ transplant recipients (2017) (2)
- Effect of Multivitamin and Multimineral Supplements on Morbidity From Infections in Older People (MAVIS trial): Pragmatic, Randomised, Double Blind, Placebo Controlled TrialAvenell A, Campbell MK, Cook JA, et al (Univ of Aberdeen, Foresterhill, Scotland) BMJ 331:324–327, 2005§ (2006) (2)
- Necrotizing Fasciitis Caused by Community-Associated Methicillin-Resistant Staphylococcus aureus in Los Angeles (2006) (2)
- Clinical Utility of Universal PCR and its Real-world Impact on Patient Management (2017) (2)
- Economic Impact of Piperacillin / Tazobactam in the Treatment of Suspected Polymicrobial Infections (2)
- Efficacy of an extract of North American ginseng containing polyfuranosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trialPredy GN, Goel V, Lovlin R, et al (Univ of Alberta, Edmonton, Canada; Univ of Western Ontario, London, Canada) CMAJ 173:1043 (2007) (2)
- HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysisMay MT, for The Antiretroviral Therapy (ART) Cohort Collaboration (Univ of Bristol, England; et al) Lancet 368:451–458, 2006§ (2007) (2)
- Economic Consequences of Cytomegalovirus Disease Among Stem Cell Transplant Recipients (2015) (2)
- Association between lymphopenia at one month post-transplant and infectious outcomes or death in heart transplant recipients. (2020) (2)
- Editorial commentary: Use of valganciclovir for prevention and treatment of cytomegalovirus disease. (2008) (2)
- Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study (2006) (2)
- Comparison of the Sepsis-2 and Sepsis-3 Definitions of Sepsis and Their Ability to Predict Mortality in a Prospective Intensive Care Unit Cohort (2017) (2)
- Changing Intravenous Tubing Containing Burettes-Reply (1985) (2)
- Factors Associated with Neutropenia Post-Heart Transplantation. (2020) (2)
- Empirical Anti-Candida Therapy Among Selected Patients in the Intensive Care Unit: A Cost-Effectiveness AnalysisGolan Y, Wolf MP, Pauker SG, et al (Tufts-New England Med Ctr, Boston) Ann Intern Med 143:857–869, 2005§ (2006) (2)
- Reduced acquisition of vancomycin-resistant enterococci: gown effect or confounding? (2003) (2)
- Campylobacter Gastroenteritis. (2020) (2)
- The use of cytomegalovirus cmv immune globulin cmvig for prevention of cmv disease in patients undergoing liver transplantation (1991) (1)
- Toxin Production by an Emerging Strain of Clostridium difficile Associated With Outbreaks of Severe Disease in North America and Europe (2006) (1)
- In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms (2003) (1)
- GB virus C and mortality from HIV infection. (2002) (1)
- 1551. The Impact of Recurrent CMV Disease on Long-Term Survival in Solid Organ Transplant Recipients (2018) (1)
- An Epidemic, Toxin Gene–Variant Strain of Clostridium difficileMcDonald LC, Killgore GE, Thompson A, et al (Centers for Disease Control and Prevention, Atlanta, Ga; Univ of Vermont, Burlington; Loyola Univ, Hines, III) N Engl J Med 353:2433–2441, 2005§ (2006) (1)
- Risk Factors for Hematogenous Complications of Intravascular Catheter-Associated Staphylococcus aureus BacteremiaFowler VG Jr, Justice A, Moore C, et al (Duke Univ, Durham, NC; Univ of Oxford, England) Clin Infect Dis 40:695–703, 2005§ (2006) (1)
- Capnocytophaga infection involving a portal-systemic vascular shunt (1990) (1)
- Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genotype as a Major Cause of Health Care-Associated Blood Stream InfectionsSeybold U, Kourbatova EV, Johnson JG, et al (Emory Univ, Atlanta, Ga; Grady Mem Hosp, Atlanta, Ga) Clin Infect Dis 42:647–656, 2006§ (2007) (1)
- Probable Person-to-Person Transmission of Avian Influenza A (H5N1)Ungchusak K, Auewarakul P, Dowell SF, et al (Thai Ministry of Public Health, Nonthaburi, Thailand; Mahidol Univ, Bangkok, Thailand; Ctrs for Disease Control and Prevention, Atlanta, Ga) N Engl J Med 352:333–340, 2005§ (2006) (1)
- PAECILOMYCES LILACINUS SINUSITIS IN A BONE MARROW TRANSPLANT RECIPIENT: CASE REPORT AND REVIEW OF THE LITERATURE (1996) (1)
- Antiviral treatment approaches for cytomegalovirus prevention in kidney transplant recipients: A systematic review of randomized controlled trials. (2020) (1)
- Effect of Pneumococcal Vaccination: A Comparison of Vaccination Rates in Patients with Bacteremic and Nonbacteremic Pneumococcal Pneumonia (2007) (1)
- Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAARTNettles RE, Kieffer TL, Kwon P, et al (Johns Hopkins Univ, Baltimore, Md; NIH, Bethesda, Md; Johns Hopkins Bloomberg School of Public Health, Baltimore, Md; et al) JAMA 293:817–829, 2005§ (2006) (1)
- Prevention of Nosocomial Transmission of Respiratory Syncytial Virus in a Newborn Nursery (1988) (1)
- Potential mortality benefit from secondary prophylaxis following CMV treatment completion may be due to confounding by transplant organ type (2019) (1)
- Factors associated with neutropenia post heart transplantation (2021) (1)
- Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study (2021) (1)
- CYTOMEGALOVIRUS AND DEATH IN LIVER TRANSPLANTATION. AUTHORS REPLY (1997) (1)
- OUTCOME OF TRANSPLANTATION OF ORGANS PROCURED FROM BACTEREMIC OR FUNGEMIC DONORS (1998) (1)
- A Hospital Outbreak of Clostridium difficile Disease Associated With Isolates Carrying Binary Toxin GenesMcEllistrem MC, Carman RJ, Gerding DN, et al (Univ of Pittsburgh, Pa; TechLab, Blacksburg, Va; Hines Veterans Affairs Hosp, III) Clin Infect Dis 40:265–272, 2005§ (2006) (1)
- Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with intravenous immune globulin. (1991) (1)
- Macrolide Resistance in Bacteremic Pneumococcal Disease: Implications for Patient ManagementMcGeer A, for the Toronto Invasive Bacterial Diseases Network (Univ of Toronto; et al) Clin Infect Dis 43:432–438, 2006§ (2007) (0)
- 1681Randomized Clinical Trial of the Recovery of Probiotics Lactobacillus rhamnosus GG (LGG) and Bifidobacterium animalis subspecies lactis (BB-12) from the Gastrointestinal (GI) Tract of Healthy Volunteers (2014) (0)
- 144: The Association between Cytomegalovirus Immune Globulin (CMVIG) Use and Long-Term Recipient and Graft Survival in Pediatric and Adult Heart Transplantation Recipients (2010) (0)
- 300 Impact of the type of mechanical circulatory support (MCS) prior to transplant on development of post-orthotopic heart transplantation (OHT) infections (2023) (0)
- Cross-Protectiveness and Immunogenicity of Influenza A/Duck/Singapore/3/97(H5) Vaccines against Infection with A/Vietnam/1203/04 (H5N1) Virus in FerretsLipatov AS, Hoffmann E, Salomon R, et al (St Jude Children's Research Hosp, Memphis, Tenn) J Infect Dis 194:1040–1043, 2006§ (2007) (0)
- The Ef fi cacy of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection in Patients With Impaired Renal Function (2014) (0)
- Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy After Sustained Virologic SuppressionSwindells S, for the AIDS Clinical Trials Group 5201 Study Team (Univ of Nebraska, Omaha; et al) JAMA 296:806–814, 2006§ (2007) (0)
- 2670. Clostridioides difficile Infection (CDI) in Solid-Organ (SOT) and Hematopoietic Stem Cell Transplant (HCT) Recipients: A Prospective Multinational Study (2019) (0)
- Year Book of Infectious Diseases, 1993. (1990) (0)
- Methicillin-Resistant Staphylococcus aureus Disease in Three Communities (2006) (0)
- Proton Pump Inhibitors and Hospitalization for Clostridium Difficile–Associated Disease: A Population-Based Study (2007) (0)
- Intense cytomegalovirus (CMV) prophylaxis reduces rejection in orthotopic liver transplantation (OLT) (2002) (0)
- Outcomes of Clostridium difficile Infection by Diagnostic Test in Inflammatory Bowel Disease: 650 (2017) (0)
- Cost-Effectiveness of a Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsHornberger J, Robertus K (SPHERE Inst and Acumen LLC, Burlingame, Calif; Veterans Affairs Palo Alto Health Care System, Calif; Stanford Univ, Calif) Ann Intern Med 145:317–325, 2006§ (2007) (0)
- Infection With Multidrug Resistant, Dual-Tropic HIV-1 and Rapid Progression to AIDS: A Case ReportMarkowitz M, Mohri H, Mehandru S, et al (Rockefeller Univ, New York; ViroLogic, San Francisco; Cabrini Med Ctr, New York) Lancet 365:1031–1038, 2005§ (2006) (0)
- Varicella Vaccine: The First Licensed Herpes Vaccine (1996) (0)
- 1510. Treatment of Asymptomatic Bacteriuria prior to Transcatheter Aortic Valve Replacement (2018) (0)
- SPECIAL SECTION: INFECTIONS IN TRANSPLANTATION AND OTHER IMMUNOCOMPROMISED HOSTS (2000) (0)
- Benefit of Appropriate Empirical Antibiotic Treatment: Thirty-day Mortality and Duration of Hospital StayLeibovici L, for the TREAT Study Group (Rabin Med Ctr, Petah-Tiqva, Israel; et al) Am J Med 119:970–976, 2006§ (2007) (0)
- CorrelatIon of MrSa naSal ColonIzatIon and MrSa-aSSoCIated lower reSPIratory traCt InfeCtIon (2013) (0)
- Impact of provider-selected indication requirement on urine test utilization and positivity (2022) (0)
- Symposium to honor the legacy of Francis P. Tally, MD. Introduction. (2010) (0)
- Reply to Alder and Eisenstein (2005) (0)
- INFLUENZA VIRUS VACCINE 1993–1994 (ADAPTED WITH MINOR MODIFICATION FROM MMWR) (1993) (0)
- 512. The relationship of Clostridioides difficile in-vitro antibiotic resistance, prior exposure to antibiotics and ribotype: A single center study (2022) (0)
- Sex- and age-based comparison of serum immunoglobulins following liver transplantation. (2023) (0)
- 2567. Effect of Broad vs. Narrow-Spectrum Clostridioides difficile Treatment on Human Stool Bile Acid Composition Over Time (2019) (0)
- High-risk transplantation : proceedings of symposium on held in conjunction with the 13th annual meeting of the American Society of Transplant Physicians, May 16-18, 1994, Chicago, Illinois (1994) (0)
- An Improvement in Virologic Response to Highly Active Antiretroviral Therapy in Clinical Practice From 1996 Through 2002Moore RD, Keruly JC, Gebo KA, et al (Johns Hopkins Univ, Baltimore, Md) J Acquir Immune Defic Syndr 39:195–198, 2005§ (2006) (0)
- Adults with Invasive Pneumococcal Disease: Missed Opportunities for VaccinationKyaw MH, and the Active Bacterial Core Surveillance Program of the Emerging Infections Program Network (Centers for Disease Control and Prevention, Atlanta, Ga; et al) Am J Prev Med 31:286–292, 2006§ (2007) (0)
- CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trialHirschel B, for the Staccato Study Group, the Swiss HIV Cohort Study (Geneva Univ Hosp; et al) Lancet 368:459–465, 2006§ (2007) (0)
- Evaluation of the Clinical Impact of the Biofire Filmarray® Rapid Multiplex PCR Assay in Blood Culture Identification Combined with Antimicrobial Stewardship Intervention (2017) (0)
- Factors Associated with Neutropenia Post-Heart Transplantation (0)
- In Vitro Susceptibilities of the Bacteroides fragilis Group Species: Change in Isolation Rates Significantly Affects Overall Susceptibility Data (2002) (0)
- Book Review Antibiotic Optimization: Concepts and Strategies In Clinical Practice (Infectious Disease and Therapy. Vol. 33.) Edited by Robert C. Owens, Jr., Paul G. Ambrose, and Charles H. Nightingale. 663 pp. New York, Marcel Dekker, 2005. $179.95. 0-8247-5431-X (2005) (0)
- In Vitro Evaluation of the Activity of Aztreonam-Avibactam against 341 Recent Clinical Isolates of Anaerobes (2021) (0)
- against Respiratory Syncytial Virus Disease by Using Standard Intravenous Immune Globulin (2003) (0)
- 778: Defying MRSA and Eliminating Bacteremia in a Surgical ICU Without Active Surveillance (2013) (0)
- In Vitro Evaluation of Cytomegalovirus-Specific Hyperimmune Globulins Versus Standard Intravenous Immunoglobulins.: Abstract# D2338 (2014) (0)
- Expert Professors CMV in Transplantation (2008) (0)
- The Ef fi cacy of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection in Patients With Impaired Renal Function (2014) (0)
- Effecting the culture: Impact of changing urinalysis with reflex to culture criteria on culture rates and outcomes (2022) (0)
- Changes in Invasive Pneumococcal Disease among HIV-Infected Adults Living in the Era of Childhood Pneumococcal ImmunizationFlannery B, Heffernan RT, Harrison LH, et al (Ctrs for Disease Control and Prevention, Atlanta, Ga; Connecticut Emerging Infections Program, Hartford; Johns Hopkins Bloomberg Sc (2007) (0)
- 672. The Impact on Humans of Treating Dogs with Amoxicillin/Clavulanate (2018) (0)
- Initial highly-active antiretroviral therapy with a protease inhibitor versus a nonnucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect metaanalysesChou R, Fu R, Huffman LH, et al (Oregon Health and Science Univ, Portland) Lancet 368:1503–1515, 2006§ (2007) (0)
- Changing the use of isolated urine-culture testing with diagnostic testing stewardship (2022) (0)
- An Evaluation of Echinacea angustifolia in Experimental Rhinovirus InfectionsTurner RB, Bauer R, Woelkart K, et al (Univ of Virginia, Charlottesville; Karl-Franzens-Universitaet, Graz, Austria; Med Univ of South Carolina, Charleston; et al) N Engl J Med 353:341–348, 2005§ (2006) (0)
- 1706. Association between Cytomegalovirus Infection/Disease and Morbidity and Mortality in Kidney Transplantation: A Systematic Literature Review of Observational Studies (2020) (0)
- Book ReviewPrevention and Control of Nosocomial Infections (1987) (0)
- Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing nonnucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: openlabel randomised trial (2007) (0)
- 937. A Clinical Prediction Tool to Determine Risk of Infection in the First Year Following Heart Transplant (2021) (0)
- Blood Cultures Drawn from Indwelling Central Venous Catheters (2000) (0)
- New Treatments for Staphylococcal Endocarditis (2009) (0)
- 2506. Reactivation of Latent Cytomegalovirus Infection Following Major Surgery: Risk Factors and Outcomes (2018) (0)
- The Impact of Enhanced Antimicrobial Stewardship Support on Antibiotic Starts in Long-Term Care Facilities (2020) (0)
- Effecting the culture: Impact of changing urinalysis with reflex culture criteria on culture rates and outcomes (2022) (0)
- Female sex and advanced age are associated with invasive cytomegalovirus disease in solid organ transplant recipients (2022) (0)
- In Memoriam: Victor L. Yu, MD. (2022) (0)
- Do Emergency Department Blood Cultures Change Practice in Patients With Pneumonia?Kennedy M, Bates DW, Wright SB, et al (Harvard Med School; Brigham and Women's Hosp, Boston; Beth Israel Deaconess Med Ctr, Boston) Ann Emerg Med 46:393–400, 2005§ (2006) (0)
- Multicenter Evaluation of the In Vitro Susceptibility of Staphylococci to Vancomycin (2006) (0)
- 28 Analysis of the Cytomegalovirus (CMV) gB vaccine with MF 59 adjuvant (CMVgB) in CMV seronegative patients with renal failure on a transplant list (2006) (0)
- Impact of Body Mass Index (BMI) on the Effect of a Lactobacillus Rhamnosus GG (LGG)/Bifidobacterium Animalis Subspecies Lactis BB-12 (BB-12) Combination on Gut Microbiota (P20-023-19). (2019) (0)
- Reply to van Hal et al (2011) (0)
- Difference in absolute lymphocyte count among male and female heart transplant recipients (2021) (0)
- a Broad Spectrum of Recent Clinical Activity of Ceftolozane-Tazobactam against (2014) (0)
- Impact of antimicrobial use in dogs on antimicrobial resistance and shared flora with human owners (2023) (0)
- A U.S. Population-Based Survey of Staphylococcus aureus ColonizationGraham PL III, Lin SX, Larson EL (Columbia Univ, New York) Ann Intern Med144:318–325, 2006§ (2007) (0)
- 2578. Narrow-Spectrum Antibiotic Treatment of Clostridium difficile Infection Improves Preservation of Intestinal Metabolic Profile (2019) (0)
- Randomized, Double-Blind Comparison of Once-Weekly Dalbavancin versus Twice-Daily Linezolid Therapy for the Treatment of Complicated Skin and Skin Structure Infections (2007) (0)
- Transplant Infections, Raleigh A. Bowden, Per Ljungman, Carlos V. Paya (Eds.). Lippincott-Raven Publishers, Philadelphia (1998), 425, with illus, $145, (telephone: 800-777-2295),, ISBN: 0-397-58776-7 (1999) (0)
- 1669. A US Based National Surveillance Study for the Susceptibility and Epidemiology of Clostridioides difficile Associated Diarrheal Isolates with Special Reference to Ridinilazole: 2020-2021 (2022) (0)
- Vancomycin‐resistant enterococcal infections: Cause for concern? (2003) (0)
- 1774. Ridinilazole (RDZ) for Clostridium difficile infection (CDI): Correlation of In Vitro Spectrum of Activity with Human Gut Microbiome Profiles from a Phase 2 Clinical Trial (2018) (0)
- Cytomegalovirus and Death in Liver Transplantation: Reply (1997) (0)
- A Prospective, Randomized, and Comparative Study of 3 Different Methods for the Diagnosis of Intravascular Catheter ColonizationBouza E, Alvarado N, Alcalá L, et al (Hospital General Universitario Gregorio Maranñon, Madrid) Clin Infect Dis 40:1096–1100, 2005§ (2006) (0)
- Efficacy of an Acellular Pertussis Vaccine Among Adolescents and AdultsWard JI, for the APERT Study Group (UCLA, Torrance, Calif; et al) N Engl J Med 353:1555–1563, 2005§ (2006) (0)
- Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-blind Phase 3 Comparison Study With Vancomycin-Aztreonam (2006) (0)
- Risks and Epidemiology of Infections Associated with Ventricular Assist Devices and Heart Transplantation (2016) (0)
- Use of Gastric Acid–Suppressive Agents and the Risk of Community-Acquired Clostridium difficile–Associated DiseaseDial S, Delaney JAC, Barkun AN, et al (McGill Univ, Montreal) JAMA 294:2989–2995, 2005§ (2006) (0)
- Antibiotic Therapy and 48-Hour Mortality for Patients with PneumoniaMortensen EM, Restrepo Ml, Anzueto A, et al (South Texas Veterans Health Care System, San Antonio) Am J Med 119:859–864, 2006§ (2007) (0)
- THE ASSOCIATION BETWEEN CYTOMEGALOVIRUS IMMUNE GLOBULIN (CMVIG) USE AND LONG-TERM RECIPIENT AND GRAFT SURVIVAL IN PEDIATRIC HEART TRANSPLANTATION RECIPIENTS: 543 (2010) (0)
- Cytomegalovirus Reactivation and Relapse Following Allogeneic Stem Cell Transplantation Using a Reduced Intensity Conditioning Regimen. (2004) (0)
- 1537. Reactivation of Latent Cytomegalovirus Infection in Patients with Rheumatologic Disease: A Case–Control Study (2018) (0)
- Resistant Aspergillus Species in Lung Transplant A 10 Year Experience (2021) (0)
- Cytomegalovirus hyperimmune globulin. (1992) (0)
- Outpatient parenteral antimicrobial therapy (OPAT) in the republic of Ireland: results of a national survey (2013) (0)
- Phase III trial of valacyclovir for the prevention of shingles after hematopoietic stem cell transplantation (2006) (0)
- Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections (2007) (0)
- Interactive Cases in Transplant ID (2015) (0)
- Intravenous Tubing with Burettes Can be Safely Changed at 48-Hour Intervals (1985) (0)
- 833Lactobacillus GG (LGG) Does Not Eliminate Colonization by Vancomycin Resistant Enterococcus (VRE) in Adults with Comorbidities (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David R. Snydman?
David R. Snydman is affiliated with the following schools:
